Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Legislation (77)
- Safety monitoring and information (41)
- Advertising (25)
- Manufacturing (19)
- Labelling and packaging (17)
- COVID-19 (15)
- Vaping hub (13)
- Compliance and enforcement (7)
- Scheduling (national classification system) (6)
- Import and export (2)
- Sunscreens (2)
- Clinical trials (1)
- Committees and advisory bodies (1)
- Medicinal cannabis hub (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
334 result(s) found, displaying 301 to 325
-
Safety updatesThe TGA Prescription Medicines Streamlined Submissions Process Newsletter [formerly the Prescription medicine BPR update (BPR update)] reports on progress of the streamlined submission process.
-
Safety updatesThe Therapeutic Goods Administration (TGA) has received reports of haemodialysis catheters becoming dislodged at the Luer lock connection point. In some cases, the dislodgment was not detected, as the catheter and all connections were out of sight.
-
Safety updatesThe Prescription medicine BPR update (BPR update) reports on progress of the streamlined submission process. Each quarter, an update is provided on the PI/CMI project and the AusPAR project.
-
Safety updatesThe TGA's Incident Reporting and Investigation Scheme receives reports about the safety and performance of medical devices as part of its ongoing monitoring of products supplied in Australia. As part of this process the TGA has recently reviewed several reports associated with repaired endoscopes. These reports relate to the quality of the repair and the use of unsuitable parts.
-
Regulatory decision noticesTherapeutic Goods Order No. 1 of 2010.
-
Regulatory decision noticesThis Order may be cited as the Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2004.
-
Regulatory decision noticesListing notice - fungal enzymes
-
Regulatory decision noticesListing notice - curcumin
-
Regulatory decision noticesListing notice - iron phosphate
-
Regulatory decision noticesListing notice - Terminalia ferdinandiana (Kakadu plum)
-
Regulatory decision noticesListing notice - sodium sulfate
-
Regulatory decision noticesListing notice - cold-pressed neem (Azadirachta indica) seed oil
-
Regulatory decision noticesListing notice - Trametes versicolor hyphae aqueous extract - powder
-
Regulatory decision noticesListing notice - boric acid, borax, sodium perborate, borax pentahydrate, molybdenum trioxide, magnesium phosphate dibasic trihydrate
-
Regulatory decision noticesListing notice - emu oil
-
Regulatory decision noticesListing notice - zeaxanthin
-
-
Regulatory decision noticesListing notice - activated charcoal
-
Regulatory decision noticesListing notice - bovine colostrum powder
-
Regulatory decision noticesListing notice - bovine colostrum powder
-
Regulatory decision noticesListing notice - demineralised fish proteoglycan extract
-
Regulatory decision noticesListing notice - black boned chicken powder, conifer phytosterol complex
-
Regulatory decision noticesListing notice - (S)-S-Adenosylmethionine & ademetionine in the form of sulfate, tosylate or mixed sulfate/tosylate salts
-
Regulatory decision noticesListing notice - Streptococcus thermophilus, Morinda citrifolia fruit juice, Pseudowintera colorata leaf
-
Regulatory decision noticesListing notice - lycopene, thiamine phosphoric acid ester chloride, sugar cane wax alcohols